Benitec Biopharma Inc. Reports Net Loss of $19.6 Million for Fiscal Year 2023
Annual Revenue of $75 Million
By USInMinutes
Published - Sep 21, 2023, 08:07 AM ET
Last Updated - Sep 21, 2023, 08:07 AM EDT
Benitec Biopharma Inc. [BNTC], a leading biotechnology company, has released its financial results for the fiscal year ended June 30, 2023. The company reported a net loss of $19.6 million for the year, with annual revenue of $75 million.
Financial Performance
Despite the net loss, Benitec Biopharma Inc. has shown resilience in its financial performance. The company's revenue increased slightly from the previous year, indicating growth in its customer base and product offerings. However, the operating expenses also increased, primarily driven by higher research and development costs.
